Results

Total Results: 1,518 records

Showing results for "symptoms".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
    February 11, 2013 - need for caution due to potential adverse reactions) in treating post-traumatic stress and related symptoms … We did, however, include these outcomes for studies that also looked at traumatic stress symptoms … TEP #5 Introduction The report focuses too heavily on PTSD-type symptoms as characterizing traumatic … We did, however, include these outcomes for studies that also looked at traumatic stress symptoms … Not symptoms or diagnosis.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
    September 10, 2012 - In both instances, all patients in the experimental group were effectively cured of all symptoms and … the patients all suffered from advanced asthmatic symptoms and as many as 20 other illnesses. … My asthma symptoms started abating in two weeks, and, while not completely "cured", I have had no attacks … Clinical results were mostly equivalent: significant decreases of >50% in panic symptoms, clinically … significant decreases in asthma symptoms, improvement in asthma quality of life, and maintenance of
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - vs. 61 vs. 65 years Female: 29% vs. 35% vs. 28% Race: - Caucasian: 41% vs. 33% vs. 37% Duration of symptoms … NR 6 months Proportion of patients with high levels of symptoms: - HAD Depression score >10: 8 (44.4% … B Age: 66 vs. 66 years Female: NR Race: NR Duration of symptoms: NR Pain etiology/type or diagnostic … C Age: 39 vs. 36 vs. 37 years Female: 20% vs. 24% vs. 19% Race/Ethnicity: NR Duration of Symptoms: 6 … B Age: 38 vs. 33 years Female: 49% vs. 51% Race/Ethnicity: NR Duration of Symptoms: 12 vs. 18 months
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - vs. 61 vs. 65 years Female: 29% vs. 35% vs. 28% Race: - Caucasian: 41% vs. 33% vs. 37% Duration of symptoms … NR 6 months Proportion of patients with high levels of symptoms: - HAD Depression score >10: 8 (44.4% … B Age: 66 vs. 66 years Female: NR Race: NR Duration of symptoms: NR Pain etiology/type or diagnostic … C Age: 39 vs. 36 vs. 37 years Female: 20% vs. 24% vs. 19% Race/Ethnicity: NR Duration of Symptoms: 6 … B Age: 38 vs. 33 years Female: 49% vs. 51% Race/Ethnicity: NR Duration of Symptoms: 12 vs. 18 months
  5. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
    April 01, 2011 - Outcomes included changes in core ASD symptoms and in commonly associated symptoms (Figure A). … , a few medications show benefit for repetitive behaviors or associated symptoms. … Individual therapies are developed and tested to ameliorate specific symptoms or groups of symptoms, … Change in autism core symptoms with early intervention: predictors and outcomes. … Change in autism core symptoms with intervention.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
    February 10, 2010 - characteristics varies among susceptible individuals leading to differences in disease progression and symptomsSymptoms can include shortness of breath, cough, wheezing, and chest pain or tightness.1 When poorly … achieve and maintain control of persistent asthma and quick-relief medications used to treat acute symptoms … (e.g., cough, wheezing, dyspnea, nocturnal symptoms) • Health-related quality of life (general and/ … (e.g., cough, wheezing, dyspnea, nocturnal symptoms)  Health-related quality of life (general
  7. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
    February 01, 2015 - Most available dementia and AD interventions are approved to manage symptoms; however, promising research … due to the difficulties associated with specifically quantifying improvements in disease state and symptoms … Researchers hypothesize that reduced serotonin levels are a primary cause of agitation symptoms in … trial indicated that citalopram was more effective than placebo in improving patients’ agitation symptoms … Food and Drug Administration (FDA) treat only AD symptoms; they are not disease-modifying.
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
    February 01, 2012 - NA NA NA Moderate SOE NA Tic severity NA NA NA NA Moderate SOE aBehavioral symptoms defined by … These side effects include extra-pyramidal symptoms (EPS). … However, SGAs did not differ from placebo for depression symptoms in this group (low SOE). … ; HRQL=health related quality of life; KQ=key question; PANSS=Positive and Negative Symptoms Scale. … specific to disorders (e.g., positive symptoms of schizophrenia) or for the disorders themselves.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
    November 21, 2019 - worsening of illness such as worsening functional status, or frequent phone calls indicating uncontrolled symptoms … or symptom burden (includes multidimensional symptom tools and key symptoms of pain, dyspnea, fatigue … or psychological well-being  Caregiver burden, caregiver impact or caregiver strain  Patient symptoms … or symptom burden (includes multidimensional symptom tools and key symptoms of Studies that do not … disciplines are involved, schedules of visits and assessments, and any standard elements such as symptoms
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
    May 01, 2013 - Gastroparesis Definition and Prevalence Gastroparesis is a condition in which patients experience symptoms … of delayed gastric emptying in the absence of an actual physical blockage.1 The most common symptoms … Evaluation of Possible Gastroparesis A standard assessment for patients with typical symptoms (e.g. … Antroduodenal manometry may help differentiate myopathic and neuropathic etiologies of symptoms. … Clinicians should ask about warning signs such as new onset of symptoms, obstructive symptoms, rectal
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
    December 01, 2015 - Clinical symptoms and signs suggestive of appendicitis include a history of central abdominal pain … Clinical symptoms and signs can be evaluated relatively easily and inexpensively. … results for selected clinical symptoms and signs. … Symptoms and signs had limited test performance when used in isolation. … They may, for example, have more severe symptoms or have atypical findings on other tests.
  12. effectivehealthcare.ahrq.gov/sites/default/files/asthma-self-mgmt-summary.pdf
    April 01, 2020 -  Frequently reported outcomes were asthma control, asthma knowledge, symptoms, quality of life,
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharma-ptsd-update-summary.pdf
    November 01, 2020 - People with PTSD have symptoms such as flashbacks, avoidance of trauma-related stimuli, negative beliefs … These symptoms reduce quality of life and functioning. … diagnosis (i.e., no longer meeting criteria for PTSD) or clinically meaningful response/remission of symptoms … the included studies reported loss of PTSD diagnosis or clinically meaningful response/remission of symptoms
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - reinfection vary by factors such as initial antibody levels, patient characteristics, presence of symptoms … Seropositivity at baseline also reduced the incidence of symptoms associated with COVID-19, such as … or mild symptoms: adjusted HR 6.6 (95% CI, 2.6-17), p<0.001 Masia, 2021* 132 Median 6 days and … (persons with 0-2 symptoms had higher risk of lacking antibodies compared with persons with 6-9 symptoms … compared to no symptoms: Adjusted OR 0.23, 95% CI 0.19-0.29, p<0.001 and adjusted OR classic symptoms
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
    March 01, 2016 - ages of 15 and 50 have uterine fibroids.1-4 More than 15 million of them will experience associated symptoms … or health concerns.5,6 A disproportionate number of black women are among those with symptoms in part … well as concerns about influence on fertility and pregnancy outcomes.9 Fibroids are prevalent and symptoms … Food and Drug Administration (FDA) for treatment of fibroid symptoms, though several medications are … symptoms.
  16. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
    November 15, 2018 - Symptoms or signs must persist ≥24 hours, or if documented by CT, MRI or autopsy, the duration of symptomsSymptoms or signs must persist ≥24 hours, or if documented by CT, MRI or autopsy, the duration of … symptoms/signs may be less than 24 hours. … Cardiac death with symptoms suggestive of myocardial ischemia and presumed new ischemic ECG changes … In addition, either (i) symptoms suggestive of myocardial ischemia or (ii) new ischemic ECG changes
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
    January 01, 2014 - A question of interest is whether any combination of clinical signs and symptoms and laboratory tests … What is the accuracy of clinical signs and symptoms and other diagnostic tests (such as serum uric … How does the diagnostic accuracy of clinical signs and symptoms and other tests vary by affected joint … # PICOTs • Population(s) (KQ1 and 2): o Adults (18 years and over) presenting with symptoms (e.g … Tests to be included are clinical examination for physical signs, symptoms, and history; ultrasonography
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0107_05-19-2009.pdf
    January 01, 2009 - Outcome(s): Prevention of the onset of asthma and additional sensitivities; significant reductions in symptoms … Patients benefit by improved allergic symptoms that do not respond to standard pharmacotherapy or allergen
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - conditions such as seizure disorders, hyperactivity, and anxiety.4 The manifestation and severity of symptoms … account a child’s developmental context; however treatment is frequently complicated by emergent symptoms … KQ1b: What are the effects on commonly associated symptoms (e.g. motor, sensory, medical, mood/anxiety … KQ1c: What are the longer-term effects (>6 mos) on core symptoms (e.g. social deficits, communication … KQ1d: What are the longer-term effects (>6 mos) on commonly associated symptoms (e.g.
  20. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - conditions such as seizure disorders, hyperactivity, and anxiety.4 The manifestation and severity of symptoms … account a child’s developmental context; however treatment is frequently complicated by emergent symptoms … KQ1b: What are the effects on commonly associated symptoms (e.g. motor, sensory, medical, mood/anxiety … KQ1c: What are the longer-term effects (>6 mos) on core symptoms (e.g. social deficits, communication … KQ1d: What are the longer-term effects (>6 mos) on commonly associated symptoms (e.g.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: